<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046721">
  <TermName>2IT-BAD monoclonal antibody 170</TermName>
  <TermPronunciation>(… MAH-noh-KLOH-nul AN-tee-BAH-dee …)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to a protein called MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000709988" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;2IT-BAD monoclonal antibody 170&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000709989" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anticuerpo monoclonal 170 2IT-BAD&quot;" language="es" id="_4"/>
  <SpanishTermName>anticuerpo monoclonal 170 2IT-BAD</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Se elabora enlazando un anticuerpo monoclonal que se llama 170, que se une  a una proteína que se llama MUC-1, con una sustancia que se llama 2IT-BAD; la sustancia resultante se une con sustancias radiactivas. El anticuerpo monoclonal 170 2IT-BAD se puede usar para detectar células cancerosas y destruirlas. Es un tipo de inmunoconjugado.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2010-04-30</DateLastModified>
</GlossaryTerm>
